Thistle J L, Cleary P A, Lachin J M, Tyor M P, Hersh T
Ann Intern Med. 1984 Aug;101(2):171-5. doi: 10.7326/0003-4819-101-2-171.
The National Cooperative Gallstone Study, a double-masked, placebo-controlled, therapeutic trial of chenodiol (chenodeoxycholic acid), provided an opportunity to study the natural history of cholelithiasis in patients who choose nonsurgical management. The major component of the study comprised 916 patients, 305 of whom were randomly assigned to receive a placebo for 24 months. Among these 305 patients, the probability of having biliary tract pain during the 24 months of prospective evaluation was significantly increased if the patient had had a history of biliary tract pain in the 12 months before entry into the study (69% versus 31%). Thirty-eight percent of patients had stone growth (greater than 0.5 cm3), and 18% had a spontaneous decrease in stone volume. Despite the high incidence of biliary tract pain, nonelective cholecystectomy was required in only 4% of patients during the 24 months.
全国胆石症合作研究是一项使用鹅去氧胆酸(chenodeoxycholic acid)进行的双盲、安慰剂对照治疗试验,为研究选择非手术治疗的胆石症患者的自然病史提供了机会。该研究的主要部分包括916名患者,其中305名被随机分配接受24个月的安慰剂治疗。在这305名患者中,如果患者在进入研究前的12个月内有胆道疼痛史,那么在前瞻性评估的24个月内发生胆道疼痛的概率会显著增加(69%对31%)。38%的患者结石增大(大于0.5 cm³),18%的患者结石体积自发减小。尽管胆道疼痛的发生率很高,但在24个月期间只有4%的患者需要进行非选择性胆囊切除术。